Jefferies Downgrades IVERIC bio to Hold, Lowers Price Target to $20

Jefferies analyst Chris Howerton downgrades IVERIC bio (NASDAQ:ISEE) from Buy to Hold and lowers the price target from $30 to $20.

Jefferies analyst Chris Howerton downgrades IVERIC bio (NASDAQ:ISEE) from Buy to Hold and lowers the price target from $30 to $20.

Total
0
Shares
Related Posts